LPL Financial
HRMY icon

LPL Financial’s Harmony Biosciences HRMY Stock Holding History

LPL Financial’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Buy
8,372
+444
+6% +$14K ﹤0.01% 5440
2026
Q1 		$222K Buy
+7,928
New +$260K ﹤0.01% 5422
2025
Q4 		– Sell
-11,384
Closed -$314K – 5956
2025
Q3 		$314K Sell
11,384
-2,053
-15% -$70.7K ﹤0.01% 5019
2025
Q2 		$425K Buy
13,437
+5,064
+60% +$163K ﹤0.01% 4513
2025
Q1 		$278K Buy
+8,373
New +$300K ﹤0.01% 4632

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LPL Financial's HRMY Position: Q2 2026 in Review

LPL Financial increased its Harmony Biosciences (HRMY) stake by 5.6% in Q2 2026, buying an estimated $14K and bringing the position to 8,372 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #5440.

LPL Financial first reported a position in HRMY in Q1 2025 and has held it in 5 quarters since. The position peaked at $425K in Q2 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • LPL Financial held 8,372 shares of Harmony Biosciences worth $305K as of Q2 2026.
  • LPL Financial bought 444 Harmony Biosciences shares in Q2 2026, an estimated $14K.
  • Harmony Biosciences made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5440 holding.
  • LPL Financial first reported a position in Harmony Biosciences in Q1 2025 and has held it in 5 quarters since.
  • LPL Financial's Harmony Biosciences position peaked at $425K in Q2 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.